Berry Genomics Co.,Ltd reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 667.33 million compared to CNY 694.74 million a year ago. Revenue was CNY 680.3 million compared to CNY 733.61 million a year ago. Net loss was CNY 18.61 million compared to net income of CNY 31.23 million a year ago. Basic loss per share from continuing operations was CNY 0.06 compared to basic earnings per share from continuing operations of CNY 0.0881 a year ago. Diluted loss per share from continuing operations was CNY 0.06 compared to diluted earnings per share from continuing operations of CNY 0.0881 a year ago.